FC
DXCM icon

Farringdon Capital’s DexCom DXCM Stock Holding History

Farringdon Capital’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$844K Buy
+13,437
New +$936K 0.18% 155

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Farringdon Capital's DXCM Position: Q1 2026 in Review

Farringdon Capital opened a new position in DexCom (DXCM) in Q1 2026: 13,437 shares worth $844K. The stake represents 0.18% of the portfolio and ranks #155 among its holdings.

956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Farringdon Capital held 13,437 shares of DexCom worth $844K as of Q1 2026.
  • DexCom was a new Farringdon Capital position in Q1 2026.
  • DexCom made up 0.18% of Farringdon Capital's portfolio in Q1 2026, its #155 holding.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Farringdon Capital's 13F filing for Q1 2026, filed 15 May 2026.